China Kidney Preservation Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

China's kidney preservation sector operates within a complex transplantation ecosystem that includes the China Organ Transplant Response System (COTRS), which coordinates deceased donor allocation across a network of certified transplant hospitals. The market covers preservation solutions, cold storage systems, and increasingly, machine perfusion technologies including both hypothermic machine perfusion (HMP) and normothermic machine perfusion (NMP) platforms. Clinical studies from Chinese transplant centers have examined outcomes related to cold ischemia time and preservation solution utilization, informing ongoing refinements to clinical protocols across major medical centers.

• •Machine perfusion technology is gaining clinical adoption alongside traditional cold storage methods
• •Chinese transplant centers have published multi-center studies examining renal preservation outcomes and cold ischemia time
• •Official agencies track transplant volumes but do not publish standalone financial market size figures for kidney preservation specifically

The Asia-Pacific region is the fastest-growing market for specialty healthcare and renal treatment globally, with projections indicating a compound annual growth rate of approximately 6.9 percent through 2030. China leads healthcare infrastructure expansion across the region, with growth rates in medical infrastructure investment exceeding 10 percent annually. Rising prevalence of end-stage renal disease, increasing deceased donor programs, and adoption of advanced perfusion technologies are primary demand drivers for preservation solutions and equipment.

• •Expanding deceased organ donation programs have increased demand for standardized preservation protocols and equipment
• •Technological transition from static cold storage to dynamic machine perfusion is driving equipment replacement cycles
• •China's position as the fastest-expanding healthcare infrastructure market in Asia-Pacific underpins investment in transplant-related technologies

Within the broader organ preservation and renal treatment landscape, the market segments by preservation modality, static cold storage, hypothermic machine perfusion, and normothermic machine perfusion, with machine perfusion representing the fastest-growing segment globally. China dominates the East Asia sub-region given its transplant volume and ongoing infrastructure investment, while Southeast Asian markets are at earlier adoption stages for advanced perfusion technologies. The kidney preservation segment sits within a broader biopharmaceutical and medical device market projected to reach substantial scale through 2030.

• •East Asia accounts for the largest share of regional demand, led by China's transplant center network
• •Machine perfusion platforms are emerging as the highest-growth technology segment
• •South and Southeast Asian markets represent developing opportunities as healthcare infrastructure expands

What are the recent trends and outlook?

Industry projections indicate continued expansion of the organ preservation and renal treatment sector through 2030, with the broader biopharmaceutical and organ preservation technology market expected to sustain a high single-digit growth trajectory. Research and clinical development is increasingly focused on normothermic perfusion as a potential standard of care, alongside innovations in preservation solution chemistry. The outlook for China's kidney preservation market remains tied to policy decisions regarding deceased donor program scale-up, investment in transplant center modernization, and clinical adoption of next-generation perfusion technologies.

• •Normothermic machine perfusion is projected to gain broader clinical adoption as evidence base expands
• •Regional growth through 2030 is expected to outpace mature Western markets
• •Ongoing infrastructure investment and transplant center expansion support long-term equipment and solution demand